logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Larry Ellingsworth

This inventor holds 9 USPTO granted patents, plus 1 CIPO patent. Top assignees: Collagen Corporation, Celtrix Pharmaceuticals, Inc., Other. Active years: 1988-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Larry Ellingsworth. Retrieved from https://idiyas.com/inventor/larry-ellingsworth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0


Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 506(Granted Patents)


Company Filing History:

goldMedal7 out of 95 
 
Collagen Corporation
 patents
silverMedal1 out of 45 
 
Celtrix Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 834,513 
Other
 patents

Years Active: 1988-1996

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 5529982 - Inducing granulocyte production or B cell production in peripheral blood (1996-06-25),
2. 5147799 - Repopulation of macrophages and granulocytes using transforming growth (1992-09-15),
3. 5008240 - Method of treating inflammation (1991-04-16),
4. 4971952 - Method of treating inflammation with cartilage inducing factor (1990-11-20),
5. 4843063 - Polypeptide cartilage-inducing factors found in bone (1989-06-27),
6. 4810691 - Polypeptide cartilage-inducing factors found in bone (1989-03-07),
7. 4806523 - Method of treating inflammation (1989-02-21),
8. 4774322 - Polypeptide cartilage-inducing factors found in bone (1988-09-27),
9. 4774228 - Polypeptide cartilage-inducing factors found in bone used in tissue (1988-09-27),

Title: Larry Ellingsworth: Innovator in Hematopoiesis and Lymphopoiesis

Introduction

Larry Ellingsworth is a notable inventor based in San Jose, CA (US). He has made significant contributions to the fields of hematopoiesis and lymphopoiesis, holding a total of 9 patents. His work focuses on innovative treatments that enhance the production of crucial blood cells.

Latest Patents

Among his latest patents, one addresses the induction of granulocyte production or B cell production in peripheral blood. This patent outlines methods for treating indications associated with dysfunction or malfunction of hematopoiesis or lymphopoiesis using a CIF (TGF-.beta.). Another significant patent involves the repopulation of macrophages and granulocytes using transforming growth factor. This treatment, either alone or in combination with a Colony Stimulating Factor, therapeutically increases the number of granulocytes and monocyte/macrophages in mammals.

Career Highlights

Throughout his career, Larry has worked with various organizations, including Collagen Corporation. His innovative approaches have led to advancements in medical treatments and therapies.

Collaborations

Larry has collaborated with notable coworkers such as Hanne Bentz and Rosa Armstrong, contributing to the development of groundbreaking solutions in his field.

Conclusion

Larry Ellingsworth's contributions to the medical field through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of blood cell production disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…